CD28-Autoantibodies in Melanoma patients - a new prognostic Marker?

被引：0
|
作者：
Schmaltz, R. [1 ]
Madjidi, D. [1 ]
Preuss, K.-D. [2 ,3 ]
Mueller, C. S. [1 ]
Pfreundschuh, M. [2 ,3 ]
Graeber, S. [4 ]
Vogt, T. [1 ]
Pfoehler, C. [1 ]
机构：
[1] Univ Klinikum Saarlandes, Klin Dermatol Venerol & Allergol, Homburg, Germany
[2] Univ Klinikum Saarlandes, Innere Med Klin 1, Homburg, Germany
[3] Univ Klinikum Saarlandes, Jose Carreras Zentrum Immun & Gentherapie, Homburg, Germany
[4] Univ Klinikum Saarlandes, Inst Med Biometrie Epidemiol & Med Informat, Homburg, Germany
来源：
JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT | 2011年 / 9卷
关键词：
D O I：
暂无
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
引用
收藏
页码：138 / 138
页数：1
相关论文
共 50 条
  • [31] MMP2 expression is a prognostic marker for primary melanoma patients
    Rotte, Anand
    Martinka, Magdalena
    Li, Gang
    CELLULAR ONCOLOGY, 2012, 35 (03) : 207 - 216
  • [32] Sentinel node biopsy in melanoma is not a good prognostic marker for individual patients
    Rees, Jonathan L.
    BMJ-BRITISH MEDICAL JOURNAL, 2013, 346
  • [33] CD28 AS A MARKER OF T CELL IMMUNOSENESCENCE IN PATIENTS ON HEMODIALYSIS
    Lioulios, Georgios
    Sampani, Erasmia
    Daikidou, Dimitra Vasileia
    Xochelli, Aliki
    Kasimatis, Efstratios
    Mitsoglou, Zoi
    Stangou, Maria
    Fylaktou, Asimina
    Papagianni, Aikaterini
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2021, 36
  • [34] CD24 expression is a new prognostic marker in breast cancer
    Kristiansen, G
    Winzer, KJ
    Mayordomo, E
    Bellach, J
    Schlüns, K
    Denkert, C
    Dahl, E
    Pilarsky, C
    Altevogt, P
    Guski, H
    Dietel, M
    CLINICAL CANCER RESEARCH, 2003, 9 (13) : 4906 - 4913
  • [35] Optimized detection of 5-S-cysteinyldopa (5-S-CD) in serum of melanoma patients: A new marker of metastatic melanoma
    Stockfleth, E
    Hartleb, J
    Meyer, T
    Heckmann, O
    Arndt, R
    Christophers, E
    Hauschild, A
    EUROPEAN JOURNAL OF CANCER, 1997, 33 : 1162 - 1162
  • [36] TRIM16 is a prognostic marker for patients with lymph node metastatic melanoma
    Cheung, Belamy B.
    Sutton, Selina K.
    Tan, Owen
    Koach, Jessica
    Liu, Bing
    Liu, Tao
    Scolyer, Richard A.
    Zhang, Xu Dong
    Marshall, Glenn M.
    CANCER RESEARCH, 2013, 73 (08)
  • [37] CD4+CD25high, CD8+CD28-cells and thyroid autoantibodies in breast cancer patients
    Bilgi, Oguz
    Karagoz, Bulent
    Turken, Orhan
    Gultepe, Mustafa
    Ozgun, Alpaslan
    Tuncel, Tolga
    Emirzeoglu, Levent
    Celik, Serkan
    Muftuoglu, Tuba
    Kandemir, Emin Gokhan
    CENTRAL EUROPEAN JOURNAL OF IMMUNOLOGY, 2014, 39 (03) : 338 - 344
  • [38] NTPROBNP - NEW PROGNOSTIC MARKER IN PATIENTS WITH AKI AND RHABDOMYOLYSIS
    Niculae, Andrei
    Peride, Ileana
    Vacaroiu, Ileana
    David, Cristiana
    Dragomirescu, Razvan
    Radulescu, Daniela
    Checherita, Ionel Alexandru
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2016, 31 : 1416 - 1417
  • [39] Multigene epigenetic signature is a prognostic marker in melanoma
    Micevic, G.
    Muthusamy, V.
    Scolyer, R.
    Bosenberg, M.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2015, 135 : S109 - S109
  • [40] Metallothionein-overexpression as a prognostic marker in melanoma
    Weinlich, G.
    GIORNALE ITALIANO DI DERMATOLOGIA E VENEREOLOGIA, 2009, 144 (01): : 27 - 38
12345